Palantir Technologies Inc. (PLTR) stock analysis: Sell

Bro's Verdict
Deep Dive

Rating

SELL

Confidence

60%

Target Price

$185.00

Upside

-11.8%

Horizon

medium

The analyst's own fair value of $185 sits roughly 12% below the current $209.76 price, and even the consensus target of $195.86 is below spot, so the 12-month risk/reward skews negative by more than 10%. Palantir is a high-quality franchise with 50.2% NTM revenue growth and 47.1% operating margins, but 131.2x forward earnings and 61.4x forward sales discount flawless execution for years, while DCF ($70-$90) and EV/Revenue/P/BV reversion ($105/$94) point to far deeper downside. Insider selling, SBC dilution and soft international commercial temper the bull case, though the wide target range ($80-$265) and the analyst's balanced Hold stance keep conviction moderate.

Executive Summary

•Palantir delivered Q4 revenue of $1.94b and TTM revenue of $6.16b, with net margin of 49.0% and operating margin of 47.1%, demonstrating rare GAAP profitability at scale for a software company.

•Forward revenue growth of 50.2% to $8.21b NTM is underpinned by US commercial AIP adoption and government defense wins, but international commercial remains a drag with Europe recovery uneven.

•Valuation is extreme: 131.2x NTM P/E, 61.4x NTM P/S, and 41.2x EV/Revenue versus a 2 year average of 20.2x, leaving no room for execution missteps.

•Insider selling of $100.8m over 90 days with zero open market buys and SBC dilution risk temper the bull case; we see fair value near $185, implying roughly 12% downside from $209.76.

Financial Snapshot

•Revenue TTM: $6.16b

•Q4 revenue: $1.94b

•Q3 revenue: $1.63b

•Q2 revenue: $1.41b

•Q1 revenue: $1.18b

•Net income TTM: $3.02b

•Q4 net income: $1.06b

•Q3 net income: $0.87b

•Q2 net income: $0.61b

•Q1 net income: $0.48b

•EPS TTM: ~$1.28 (calculated)

•Gross margin: 84.8%

•Operating margin: 47.1%

•Net margin: 49.0%

•ROE: 38.1%

•Debt/Equity: 2.1%

•Market cap: $493.15b

•Free cash flow: Not disclosed

Forward Outlook

•NTM revenue estimate: $8.21b (+50.2% YoY)

•FY+2 revenue estimate: $12.33b

•NTM EPS estimate: $1.60

•FY+2 EPS estimate: $2.30

•NTM EPS revision: $2.12 now vs $2.06 1m ago (+3.1%)

•US commercial ARR growth: Not disclosed, but implied above 50% from total revenue trajectory

•AIP bootcamp conversion: Not disclosed, but management cites a strong pipeline

•Government contracts: Maven Smart System and Army Vantage expansions expected to contribute

•International commercial: softness persists, Europe recovery expected in 2H 2027

•Margin trajectory: operating margin expected to remain above 45% as scale benefits offset SBC

Valuation Analysis

•NTM P/E: 131.2x (forward)

•NTM P/S: 61.4x (forward)

•NTM EV/EBIT: ~126x (forward, using 47.1% operating margin and net cash)

•TTM P/E: ~164x (trailing)

•BF P/E: 97.7x vs 2 year avg 94.3x (+0.2 SD); implied price at avg $202.54

•BF EV/EBITDA: 64.7x vs 2 year avg 71.7x (-0.4 SD); implied price at avg $231.85

•BF EV/EBIT: 65.2x vs 2 year avg 115.4x (-0.6 SD); implied price at avg $368.06

•BF EV/Revenue: 41.2x vs 2 year avg 20.2x (+1.4 SD); implied price at avg $105.05

•LF P/BV: 51.6x vs 2 year avg 23.1x (+1.7 SD); implied price at avg $94.08

•DCF fair value (WACC 9.5%, terminal growth 3%): $70-$90

•SNOW: ~120.6x NTM P/E, data cloud and AI exposure

•AI: -24.8x NTM P/E, early stage AI software

•BAH: ~11.5x TTM P/E, government consulting

•LDOS: ~11.2x TTM P/E, defense IT services

•Consensus price target: $195.86 (median $207.5, range $80-$265)

•Our fair value: $185, implying ~12% downside

Key Risks & Catalysts

Risks

•Valuation compression: 131.2x NTM P/E leaves no margin of safety

•SBC dilution: share count growth not disclosed but insider selling is a negative signal

•Insider selling: $100.8m net over 90 days, zero buys, Karp sold $53.6m in the largest single transaction

•Institutional positioning: 0.1% of shares held by 13F filers, 2,770 positions closed in Q3, put/call ratio 200

•International commercial softness: Europe recovery slower than expected

•Government contract concentration: reliance on US defense budgets

•Competition: hyperscalers and AI startups encroaching on data analytics

•AI hype cycle: sentiment reversal could trigger multiple contraction

Catalysts

•Maven Smart System expansion: potential $1b+ contract ceiling

•Army Vantage follow on awards: pipeline of defense AI deals

•AIP bootcamp conversion: accelerating conversion rates could drive US commercial ARR above consensus

•Europe recovery: any stabilisation in international commercial

•Goldman Sachs upgrade to Buy (2026-10-08) may drive momentum

•FY+2 EPS estimate of $2.30: if achieved, forward P/E drops to ~91x

Investment Thesis

Palantir is a high quality AI and defense software franchise with best in class margins and a growing US commercial business. Revenue growth of 50.2% NTM and GAAP profitability are impressive, but the stock trades at 131.2x forward earnings and 61.4x forward sales, multiples that discount flawless execution for years. Our DCF, using a 9.5% WACC and 3% terminal growth, yields a fair value range of $70-$90, while reversion to the 2 year average EV/Revenue and P/BV multiples implies $105.05 and $94.08 respectively. Even the consensus price target of $195.86 sits below the current $209.76 share price.

We rate PLTR a Hold with a $185 price target, reflecting balanced risk/reward. The bull case rests on AIP bootcamp conversion, US commercial ARR acceleration, and government contract wins like Maven and Army Vantage. The bear case centres on international commercial softness, SBC dilution, and insider selling that signals waning confidence. Investors should watch quarterly US commercial ARR growth and customer count additions for signs of durable momentum. A break below $150 would make the risk/reward more attractive.

Written by Buy Side Bro's AI analyst from financials, consensus, filings and recent news. General information only, not financial advice.

Palantir Technologies Inc. PLTR

Bro's Verdict
Deep Dive

Executive Summary

Financial Snapshot

Forward Outlook

Valuation Analysis

Key Risks & Catalysts

Investment Thesis

Run your own analysis free

Bro's VerdictDeep Dive

Executive Summary

Financial Snapshot

Forward Outlook

Valuation Analysis

Key Risks & Catalysts

Investment Thesis

Run your own analysis free

Bro's Verdict
Deep Dive